MIND 24/7

MIND 24/7, Higley Progression

In the 2025 National Directory of Mental Health Treatment Facilities.

Type of Care

Substance use treatment (SA); Mental health treatment (MH); Treatment for co-occurring substance use plus either serious mental illness (SMI) in adults and/or serious emotional disturbance (SED) in children (SUMH)

Service Setting

Outpatient (OP)

Facility Type

Outpatient mental health facility (OMH)

Pharmacotherapies

Haloperidol (HALOP); Aripiprazole (ARIPI); Clozapine (CLOZA); Olanzapine (OLANZ); Paliperidone (PALIP); Quetiapine (QUETI); Risperidone (RISPE); Antipsychotics used in treatment of SMI (ANTPYCH)

Treatment Approaches

Cognitive behavioral therapy (CBT); Couples/family therapy (CFT); Group therapy (GT); Integrated Mental and Substance Use Disorder treatment (IDD); Individual psychotherapy (IPT); Telemedicine/telehealth therapy (TELE)

Facility Operation (e.g., Private, Public)

Private for-profit organization (PVTP)

Payment/Insurance/Funding Accepted

Community Mental Health Block Grants (CMHG); IHS/Tribal/Urban (ITU) funds (ITU); Medicare (MC); Medicaid (MD); Federal military insurance (e.g., TRICARE) (TRICARE); Private health insurance (PI); Cash or self-payment (CASH); State mental health agency (or equivalent) funds (SMHA); State welfare or child and family services funds (SWFS)

Assessment/Pre-treatment

Screening for tobacco use (STU)

Facility Smoking Policy

Smoking permitted in designated area (SMPD)

Age Groups Accepted

Children/Adolescents (CH/AD); Young Adults (YAD); Adults (ADLT); Seniors (SNR)

Language Services

Spanish (SP)

Facility Vaping Policy

Vaping permitted in designated area (VPPD)

Ancillary Services

Family psychoeducation (FPSY); Case management service (CM)